Minerva Neurosciences (NERV) Current Assets (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Current Assets data on file, last reported at $79.1 million in Q1 2026.

• Quarterly Current Assets rose 341.32% year-over-year to $79.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $79.1 million (up 341.32% YoY) and the FY2025 annual result came in at $83.1 million, up 273.16% from the prior year.
• Current Assets retreated to $79.1 million in Q1 2026, from $83.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $83.1 million in Q4 2025 to a low of $13.0 million in Q3 2025.
• A 5-year average of $40.9 million and a median of $40.2 million in 2022 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2025 — Current Assets slumped 53.39% — and 2026, when it jumped 341.32%.
• Tracing NERV's Current Assets over 5 years: stood at $40.2 million in 2022, then gained by 4.59% to $42.0 million in 2023, then slumped by 46.98% to $22.3 million in 2024, then soared by 273.16% to $83.1 million in 2025, then slipped by 4.8% to $79.1 million in 2026.
• The last three Current Assets figures came in at $79.1 million (Q1 2026), $83.1 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.